Allergan plc (NYSE: AGN) is a bold, global pharmaceutical company. We are focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

We market a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.

We are an industry leader in Open Science, our R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach we have built one of the broadest development pipelines in the pharmaceutical industry with 50+ mid-to-late stage pipeline programs in development.